Effect of the different phosphorylated Smad2 protein localizations on the invasive breast carcinoma phenotype.
Smad2 participates in the TGF-beta signaling pathway, where it cooperates with transcription factors to regulate expression of defined genes. The purpose of this study was to investigate the expression pattern of phosphorylated Smad2 (pSmad2) in association with clinicopathological parameters and biological markers of proliferation and invasion. Immunohistochemistry was applied on paraffin-embedded sections from 164 patients with invasive breast carcinomas to detect the expression of the proteins pSmad2, ER, PR, Ki67, topoisomerase IIa, ERK2, catenin-p120, MMP-14 and TIMP-2. pSmad2 protein was detected in the nuclei of the malignant cells (68.1%) and in the tumor fibroblasts (55.2%). Nuclear pSmad2 was inversely correlated with histological grade and LN (p=0.047 and p=0.05) as well as with Ki67 and topoIIa (p=0.003 and p=0.021, respectively). There was also an inverse relation between nuclear pSmad2 and normal immunoexpression of the adhesion molecule catenin-p120 (p=0.028). Both nuclear and stromal pSmad2 were positively correlated with ERK2 of tumor fibroblasts (p=0.008 and p=0.0001, respectively), while stromal pSmad2 was furthermore related to stromal MMP-14 and tumor TIMP-2 (p=0.006 and p=0.022, respectively). Patients with high expression of cancerous pSmad2 tended to have a better prognosis, although statistic significance was never reached. pSmad2 was found to play a dual role, according to its distribution. Nuclear localization was thus found to be related to a less aggressive tumor phenotype, whereas stromal location was associated with an invasive phenotype.
Liapis
George
G
Department of Pathology of the Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Mylona
Eleni
E
Alexandrou
Paraskevi
P
Giannopoulou
Ioanna
I
Nikolaou
Irini
I
Markaki
Sofia
S
Keramopoulos
Antonios
A
Nakopoulou
Lydia
L
D001943:Breast Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008593:Menopause; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D010641:Phenotype; D010766:Phosphorylation; D051899:Smad2 Protein / Q000378:metabolism*; D016019:Survival Analysis
C497782:SMAD2 protein, human; D051899:Smad2 Protein